Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants
- PMID: 6184075
Human spleen cysteineproteinase inhibitor. Purification, fractionation into isoelectric variants and some properties of the variants
Abstract
The papain inhibitor from human spleen was purified by extraction in isotonic sucrose, acetone fractionation, papain-Sepharose affinity chromatography and gel filtration on Sephadex G-50. The purified inhibitor was fractionated by electrofocusing into four major isoelectric variants with pI values of 4.7, 5.0, 6.0 and 6.5. These variants can be classified into two groups: the acidic type, comprising the variants with pI 4.7 and 5.0, and the neutral type, comprising the variants with pI 6.0 and 6.5. The following properties distinguish the two types: 1. Immunological properties: antibodies raised against either of the neutral variants precipitated both of these, but not the acidic variants. The antiserum against the human epidermal cysteineproteinase inhibitor precipitated the acidic variants, but not the neutral variants. 2. Molecular size: two-dimensional electrophoresis of the purified inhibitor gave molecular weights of 11400 for the acidic variants and 12000 for the neutral variants. The pI 6.0 variant contained two compounds with molecular weights of 12000 and 12800. 3. Enzyme spectrum: human cathepsin B was inhibited by the acidic type, while the neutral type was a poor inhibitor. Both types inhibited cathepsin H, papain, ficin and bromelain, although the inhibition of bromelain did not exceed 70%. Human cathepsin D, bovine trypsin and chymotrypsin and porcine elastase were not inhibited by either type.
Similar articles
-
Purification and some characteristics of the human epidermal SH-protease inhibitor.J Invest Dermatol. 1978 Aug;71(2):114-8. doi: 10.1111/1523-1747.ep12546165. J Invest Dermatol. 1978. PMID: 681777
-
Partial purification and some properties of a new papain inhibitor from psoriatic scales.J Invest Dermatol. 1984 May;82(5):471-6. doi: 10.1111/1523-1747.ep12260976. J Invest Dermatol. 1984. PMID: 6392431
-
Cystatins of human placenta.Acta Biochim Pol. 1989;36(1):7-15. Acta Biochim Pol. 1989. PMID: 2787571
-
Purification and characterization of a bovine colostrum low molecular weight cysteine proteinase inhibitor.J Biochem. 1984 Jul;96(1):51-8. doi: 10.1093/oxfordjournals.jbchem.a134828. J Biochem. 1984. PMID: 6548471
-
Structural and functional aspects of papain-like cysteine proteinases and their protein inhibitors.Biol Chem. 1997 Mar-Apr;378(3-4):141-50. Biol Chem. 1997. PMID: 9165064 Review.
Cited by
-
Production of acid and neutral cysteine-proteinase inhibitors by a cultured human skin epithelium cell line.Arch Dermatol Res. 1985;277(6):452-6. doi: 10.1007/BF00510062. Arch Dermatol Res. 1985. PMID: 4051554
-
Purification and characterization of high molecular mass and low molecular mass cystatin from goat brain.Neurochem Res. 2006 Nov;31(11):1327-36. doi: 10.1007/s11064-006-9175-y. Epub 2006 Oct 25. Neurochem Res. 2006. PMID: 17063392
-
Increased expression of the stefin A cysteine proteinase inhibitor occurs in the myelomonocytic cell-infiltrated tissues of autoimmune motheaten mice.Am J Pathol. 1994 Oct;145(4):902-12. Am J Pathol. 1994. PMID: 7943179 Free PMC article.
-
Molecular background of progressive myoclonus epilepsy.EMBO J. 2003 Jul 15;22(14):3473-8. doi: 10.1093/emboj/cdg338. EMBO J. 2003. PMID: 12853462 Free PMC article. Review.
-
Dendritic reticulum cells in AIDS-related lymphadenopathy.Experientia. 1985 Sep 15;41(9):1173-5. doi: 10.1007/BF01951713. Experientia. 1985. PMID: 3876238
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Research Materials
Miscellaneous